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Abstract
Histone modifications in chromatin regulate gene expression. A transcriptional co-repressor complex containing LSD1–
CoREST–HDAC1 (termed LCH hereafter for simplicity) represses transcription by coordinately removing histone
modifications associated with transcriptional activation. RE1-silencing transcription factor (REST) recruits LCH to the
promoters of neuron-specific genes, thereby silencing their transcription in non-neuronal tissues. ZNF198 is a member of a
family of MYM-type zinc finger proteins that associate with LCH. Here, we show that ZNF198-like proteins are required for
the repression of E-cadherin (a gene known to be repressed by LSD1), but not REST-responsive genes. ZNF198 binds
preferentially to the intact LCH ternary complex, but not its individual subunits. ZNF198- and REST-binding to the LCH
complex are mutually exclusive. ZNF198 associates with chromatin independently of LCH. Furthermore, modification of
HDAC1 by small ubiquitin-like modifier (SUMO) in vitro weakens its interaction with CoREST whereas sumoylation of HDAC1
stimulates its binding to ZNF198. Finally, we mapped the LCH- and HDAC1–SUMO-binding domains of ZNF198 to tandem
repeats of MYM-type zinc fingers. Therefore, our results suggest that ZNF198, through its multiple protein-protein
interaction interfaces, helps to maintain the intact LCH complex on specific, non-REST-responsive promoters and may also
prevent SUMO-dependent dissociation of HDAC1.
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Introduction
The ordered assembly of genomic DNA into a proteinacious
substance—chromatin—allows for high-order regulation of DNA-
templated processes, such as transcription, replication, and DNA
repair. Chromatin contains repeating units of nucleosomes, which
consists of one histone H3/H4 tetramer and two H2A/H2B
dimers wrapped around by double-stranded DNA [1–3]. Polymers
of nucleosomes flanked by various lengths of linker DNA can fold
into compacted high-order structures that are subject to dynamic
regulation [4].
Post-translational modifications on the flexible tails of histones
can directly or indirectly affect chromatin structure [5]. Histone
acetylation is generally associated with transcriptional activation
and is dynamically regulated by histone acetyltransferases (HATs)
and histone deacetylases (HDACs) [5]. The effect of histone lysine
methylation, catalyzed by methyltransferases, depends on the
specific residue and degree of modification (mono-, di-, or
trimethylation) [6]. Histone H3 lysine 4 di- and trimethylation
(H3K4me2/3) is associated with active promoters [7,8], but
H3K9me2/3 is mostly associated with transcriptional repression
[9]. Lysine-specific demethylase 1 (LSD1; also known as BHC110
or AOF2) is a flavin adenine dinucleotide (FAD)-dependent amine
oxidase that demethylates histone H3K4me1/2, but not H3K4me3
[10,11]. Although LSD1 alone can demethylate bulk histones or
peptide substrates, it requires a co-factor, REST co-repressor
(CoREST), for efficient binding to nucleosomes and demethylation
of nucleosomal substrates [12–14]. The LSD1–CoREST interac-
tionalsostabilizestheLSD1proteininthecell[14].Afractionofthe
abundant class I HDACs, HDAC1 and HDAC2, associate with
LSD1–CoREST, forming an LSD1–CoREST–HDAC1/2 (LCH)
core ternary complex [15–18]. Formation of this complex on
chromatin enables HDAC1/2 and LSD1 to stimulate each other’s
activity through CoREST [19].
The LCH complex can be targeted to specific promoters
through binding to sequence-specific transcriptional factors, either
directly or indirectly. For example, RE1-silencing transcription
factor (REST), which is a Kru ¨ppel-like zinc finger-containing
protein, binds directly to CoREST and recruits the LCH complex
to neuron-specific gene promoters that contain RE1 elements, thus
repressing the expression of neuron-specific genes in non-neuronal
tissues [20,21]. In addition, LCH can be incorporated into a larger
co-repressor complex that also contains CtBP1/2 and the G9a
histone H3K9 methyltransferase [16]. CtBP1/2 in turn binds to
Kru ¨ppel-like zinc finger-containing sequence-specific repressors
ZEB1/2, which recruit this complex to chromatin [22]. Finally,
LSD1 is targeted to androgen- and estrogen-responsive promoters
through interactions with androgen receptor (AR) and possibly
estrogen receptor (ER). In this context, LSD1 activates transcrip-
tion through promoting the demethylation of H3K9me1/2 at
these promoters [23,24]. Whether the entire LCH complex is
targeted to AR- or ER-dependent promoters is unclear.
Several human proteins, including ZNF198, ZNF237, ZNF261,
ZNF262, and ZNF258, contain a stretch of unique tandem zinc
PLoS ONE | www.plosone.org 1 September 2008 | Volume 3 | Issue 9 | e3255fingers called MYM (myeloproliferative and mental retardation)
domains [25] (Figure S1). The MYM-domains of ZNF198 are
frequently fused to FGF receptor kinase in myeloproliferative
syndromes [26–28]. Disruptions near the ZNF261 gene have been
linked to X-linked mental retardation [29]. Among human MYM-
domain proteins, ZNF198, ZNF261, and ZNF262 share a similar
domain architecture and possibly perform similar functions (Figure
S1). A Drosophila homolog of these proteins, without children
(dWoc), is essential for viability, associates with chromatin, and
prevents telomere fusions [30–32]. Interestingly, ZNF198 and
ZNF261 are present in transcriptional corepressor complexes that
also contain LCH [13,14,18], although their functions in
transcriptional regulation have not been explored.
Many transcription factors and cofactors are modified by small
ubiquitin-like modifier (SUMO). Sumoylation of these factors
generally leads to transcriptional repression. For unknown reasons,
multiple subunits within a given chromatin-associated complex are
often targeted by sumoylation [33,34]. For example, ZNF198,
ZNF262, HDAC1, and LSD1 are known SUMO substrates
[33,35–37]. Sumoylation of HDAC1 has been shown to be
required for its function. Recent reports have also identified
ZNF198 as a non-covalent binding partner for SUMO [38,39].
In this study, we characterize the function and mechanism of
ZNF198-like proteins in regulating the LCH complex. We show
that depletion of ZNF198, ZNF261, and ZNF262 by RNA
interference (RNAi) in HeLa cells causes derepression of E-
cadherin, a known target of LSD1. By contrast, ZNF198-like
proteins are not required for the transcriptional repression of
several REST-responsive genes that are repressed by LSD1.
Consistent with this finding, ZNF198 selectively binds to the
LSD1–CoREST–HDAC1 ternary complex and binding of
ZNF198 to LCH prevents its interaction with REST. Similar to
dWoc, ZNF198 associates with chromatin. Depletion of ZNF198-
like proteins weakens the association of LCH with chromatin.
Furthermore, sumoylation of HDAC1 decreases its affinity toward
CoREST, but enhances its binding to ZNF198. Finally, the
tandem repeats of MYM-type zinc fingers of ZNF198 mediate its
binding to both LCH and sumoylated HDAC1. Collectively, our
results suggest that, unlike the Kru ¨ppel-like zinc fingers which bind
to DNA, the MYM-type zinc fingers of ZNF198-like proteins
mediate multiple protein-protein interactions, maintains the
integrity of the LCH complex at non-REST-responsive promoters,
and may antagonize SUMO-dependent disassembly of the LCH
complex.
Results
ZNF198 associates with LSD1, CoREST, and HDACs in
human cells
The MYM-type zinc fingers have the CX2CX19–24[F/
Y]CX3CX3[F/Y] (X is any residue) consensus motif [28]. Five
proteins in the human proteome contain tandem repeats of the
MYM-type zinc fingers, including ZNF198, ZNF261, ZNF262,
ZNF237, and ZNF258 (Figure S1). Some of the MYM zinc fingers
in ZNF237 and ZNF258 lack key conserved cysteines (Figure S1),
whereas the zinc fingers in ZNF198, ZNF261, and ZNF262 all
appear to be intact. ZNF198, ZNF261, and ZNF262 have
additional features that differentiate them from ZNF237 and
ZNF258. They contain a proline/valine-rich (P/V-rich) domain
downstream of the MYM domain. They also contain a domain at
their C-terminal region that is predicted by 3D-Jury [40] to have a
fold similar to DNA breaking-rejoining enzymes, such as Cre
recombinase. The Cre-like domain is also found in several proteins
that do not contain MYM zinc fingers (Figure S1).
ZNF198 and ZNF261 have been shown to be present in several
LSD1-containing transcriptional corepressor complexes in sub-
stoichiometric amounts [13,14,18]. To identify the major
ZNF198-interacting proteins in human cells, we immunoprecip-
itated the endogenous ZNF198 protein from HEK293 and HeLa
cells (Figure 1A and data not shown). The ZNF198-binding
proteins were detected by Colloidal blue staining followed by mass
spectrometry. LSD1, CoREST, and HDAC1/2 were present at
near stoichiometric levels. ZNF262 was also present at sub-
stoichiometric amounts. Several abundant proteins, including
tubulin, Hsp70, and dynein, were also identified in the anti-
ZNF198 IP, although they might not be specific ZNF198
interactors. This result indicates that LSD1, CoREST, and
HDAC1/2 are major binding proteins of ZNF198 in human cells
and confirms earlier findings that have demonstrated the
interactions between the LCH complex and proteins containing
MYM zinc fingers.
ZNF198-like proteins are not required for the repression
of REST-responsive genes
Through its binding to REST, the LCH complex is recruited to
neuron-specific genes and represses their transcription in non-
neuronal tissues. We first tested whether ZNF198-like proteins
were required for the repression of REST-responsive genes.
Because ZNF198, ZNF261, and ZNF262 have all been shown to
be associated with LSD1-containing corepressor complexes, we
depleted from U2OS and other human cells the three ZNF198-
like MYM proteins using RNA intereference (RNAi). As shown in
Figure 1B, RNAi against ZNF198, ZNF261, and ZNF262
effectively knocked down the levels of ZNF198 without affecting
the levels of LSD1, CoREST, or HDAC1. We did not have
antibodies against ZNF261 and ZNF262. However, quantitative
RT-PCR analysis (QPCR) confirmed that the siRNAs against
these two genes effectively reduced their mRNA levels (Figure 1C).
As a comparison, we also depleted LSD1 from human cells using
RNAi. Cells transfected with siRNA against luciferase were used
as a control. As expected, QPCR analysis revealed that LSD1
RNAi caused an up-regulation of mRNA levels of the known
LSD1 target genes, SCN3A and NCAM2 [23] (Figure 1D). By
contrast, depletion of ZNF198-like proteins did not significantly
alter the mRNA levels of SCN3A and NCAM2 (Figure 1D),
suggesting that these proteins were not required for the repression
of these putative REST-responsive neuronal genes in non-
neuronal tissues.
To identify additional genes that were repressed by LSD1, we
performed microarray analysis of RNA samples from HeLa cells
transfected with siRNAs against luciferase or LSD1 (data not
shown). Among the genes that were up-regulated by LSD1 RNAi,
we confirmed that keratin 17 (KRT17) was a REST-responsive
gene, because REST directly bound to the promoter of KRT17 as
demonstrated by chromatin immunoprecipitation (ChIP)
(Figure 2A). Using QPCR, we confirmed that LSD1 RNAi indeed
increased the mRNA levels of KRT17. Depletion of ZNF198-like
MYM proteins again had no effect on KRT17 expression
(Figure 2B). Therefore, these ZNF198-like proteins do not appear
to be required for the repression of REST-responsive genes.
ZNF198-like proteins are required for the repression of E-
cadherin
Corepressor complexes containing LSD1, CoREST, and
HDAC1 can be recruited to promoters in REST-independent
ways. E-cadherin is a well-characterized gene that is repressed by
the CtBP corepressor complex containing LSD1, but E-cadherin is
LSD1 Regulation by ZNF198
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cadherin was indeed repressed by LSD1 (Figure 2C). RNAi
against ZNF198-like MYM proteins also significantly elevated the
mRNA level of E-cadherin. Therefore, ZNF198-like proteins are
required for the repression of at least some LSD1-repressed genes
that are not regulated by REST.
ZNF198 binds selectively to the LSD1–CoREST–HDAC1
(LCH) ternary complex
We next sought to understand the mechanisms by which
ZNF198-like MYM-domain proteins regulated the LCH complex.
First, we tested whether ZNF198 bound directly to LSD1,
CoREST, or HDAC1. To do this, we purified recombinant
His6-ZNF198, GST-CoREST, His6-LSD1, and HDAC1-FLAG
(Figure 3A and 3C). Surprisingly, in GST pull-down assays,
ZNF198 did not bind efficiently to CoREST alone, LSD1–
CoREST, or HDAC1–CoREST (Figure 3B, lanes 6–8 and
Figure 3C, lanes 2 and 3). ZNF198, however, bound efficiently
to the intact LCH ternary complex (Figure 3B, lane 2; Figure 3C,
lane 1). Inhibition of HDAC1 and LSD1 activities using
trichostatin A [41] (TSA) and tranylcypromine [42] (TCP),
respectively, had no effect on the binding between ZNF198 and
LCH (Figure 3B, lanes 3–5). Furthermore, binding of ZNF198 to
LCH greatly reduced the binding of REST to LCH (Figure 3D,
lanes 5 and 6). This suggests that ZNF198-binding and REST-
binding to LCH are mutually exclusive, consistent with our finding
that ZNF198 does not appear to be required for the repression of
REST-responsive genes.
ZNF198-like proteins stabilize the LCH complex on
chromatin
Binding of ZNF198 to LCH prevents the binding of REST.
One possibility is that ZNF198 recruits LCH to specific promoters
in a manner similar to REST. However, we were unable to detect
high-affinity binding of ZNF198 to DNA in vitro (data not shown).
Prompted by the finding that the Drosophila homolog of ZNF198,
Woc, associated with chromatin, we tested whether ZNF198 also
bound to chromatin in human cells. We transfected HeLa cells
with plasmids encoding Myc-ZNF198 or its fragments. The cells
were stained with anti-Myc either with or without extraction
Figure 1. ZNF198-like proteins are not required for the repression of REST-responsive genes. (A) LSD1, CoREST, and HDAC1/2 are major
binding partners of ZNF198 in 293 cells. IP of ZNF198 from HEK293 whole cell lysates was separated on SDS-PAGE and stained with Colloidal Blue.
Bands were excised and identified by mass spectrometry. (B) HeLa cells were transfected with siRNAs against luciferase (siLuc) or ZNF198, ZNF261,
and ZNF262 (siMYM). Cell lysates were blotted with the indicated antibodies. (C & D) U2OS cells were transfected with the indicated siRNAs for three
days, followed by quantitative RT-PCR using the indicated primer sets. Cycling-time values were normalized to the housekeeping gene cyclophilin B.
Each PCR reaction was performed in triplicate, and error bars indicate the standard deviation of three separate experiments.
doi:10.1371/journal.pone.0003255.g001
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transfected cells after extraction, cells were also co-transfected with
a plasmid encoding a known chromatin-bound protein GFP-
MCM7. As expected, GFP-MCM7 remained in the nucleus after
such extraction, indicating that it was bound to chromatin [43]
(Figure 4A). Both the endogenous ZNF198 (data not shown) and
the full-length Myc-ZNF198 (Figure 4A) were diffusely nuclear
localized and this staining was resistant to extraction, consistent
with ZNF198 being bound to chromatin. Analysis of the ZNF198
fragments showed that those fragments lacking the P/V-rich
domain were not detected in the nuclei after extraction, even
though these nuclei contained GFP-MCM7 and had thus been
transfected (Figure 4A and 4B). These data indicate that the P/V-
rich domain is required for the association of ZNF198 with
chromatin. The P/V-rich region alone, however, bound to
chromatin much weaker than the full-length Myc-ZNF198 and
its larger fragments (Figure 4B). Therefore, multiple regions in
ZNF198 contribute to its association with chromatin.
Formation of an intact LSD1–CoREST–HDAC1/2 complex
on chromatin is important for optimal co-repressor activity [19].
Consistent with our in vitro finding that ZNF198 interacted
specifically with the LCH ternary complex, depletion of LSD1 by
RNAi also dramatically reduced the amounts of CoREST and
HDAC1 in the a-ZNF198 IPs (Figure 5A, top panel, compare
lanes 1 and 3). Through selective binding to the LCH ternary
complex, ZNF198 would be expected to stabilize this complex. On
the other hand, depletion of ZNF198-like MYM-domain proteins
only slightly decreased the association of LSD1 with CoREST and
HDAC1 (Figure 5A, middle panel, compare lanes 1 and 2). Thus,
ZNF198-like proteins have a role in maintaining the LCH
complex, but are not essential for its stability.
We next tested whether depletion of ZNF198-like proteins
affected the chromatin binding of LSD1 by subcellular fraction-
ation [44]. The majority of ZNF198 was found in insoluble
chromatin fractions (Figure 5B and 5C, compare supernatant and
pellets). LSD1 RNAi did not affect chromatin association of
ZNF198, suggesting that ZNF198 bound to chromatin indepen-
dently of LCH (Figure 5B and 5C). By contrast, only a small
fraction of LSD1 was associated with chromatin (Figure 5B). RNAi
of ZNF198-like proteins reduced the levels of LSD1 in the
chromatin fraction by about 2-fold (Figure 5B, compare lanes 7
and 8). This effect was more pronounced after a high-salt
extraction of the chromatin fraction (Figure 5C, compare lanes
4 and 5). Importantly, an unrelated chromatin-binding protein
MCM7 was unaffected by RNAi against ZNF198-like proteins
[45]. Therefore, ZNF198-like proteins are required for efficient
chromatin-association of LSD1 and possibly the LCH complex.
HDAC1 levels in chromatin fractions, however, were not affected
by RNAi against ZNF198-like proteins, presumably because only
a fraction of cellular HDAC1 associated with LSD1 and ZNF198
(data not shown).
To further characterize the nature of chromatin association of
ZNF198 and LSD1, we digested the chromatin fraction with
micrococcal nuclease (MNase) followed by EDTA extraction [44]
(Figure 5D). Most of MCM7 and histone H3 were released into
the supernatant by MNase digestion (Figure 5D). Although about
50% of HDAC1 and LSD1 and a small fraction of ZNF198 were
also released, significant fractions of ZNF198, LSD1, and HDAC1
remained in the pellet. Therefore, at least a portion of the LCH
complex associates with nuclease-resistant chromatin materials or
nuclear matrix or both.
Sumoylation of HDAC1 weakens its binding to CoREST
but enhances its binding to ZNF198
Both HDAC1 and LSD1 can be sumoylated. Although the
function of LSD1 sumoylation has not been established, sumoyla-
tion of HDAC1 at its C-terminal region is required for its ability to
repress transcription [37]. We were interested in how sumoylation
of HDAC1 may affect its interaction with CoREST. Since
sumoylation of HDAC1 has been shown to be important for its
repressor activity, we hypothesized that SUMO-HDAC1 might
show increased affinity for CoREST. We tested this hypothesis by
comparing binding of sumoylated and free HDAC1-FLAG to
GST-CoREST using GST pull-down assays (Figure 6A). Surpris-
ingly, free HDAC1-FLAG, but not SUMO2-HDAC1-FLAG,
bound to GST-CoREST. Thus, sumoylation of HDAC1 inhibits
its interaction with CoREST.
Recently, it has been shown that ZNF198 and LSD1 could bind
to SUMO non-covalently [38,39]. To confirm these reports, we
tested whether ZNF198, LSD1, CoREST, HDAC1, and PIASxb
Figure 2. ZNF198-like proteins are required for the repression of E-cadherin. (A) ChIP analysis reveals that REST binds to the promoter of
keratin 17 (KRT17). (B) LSD1 is required for the repression of KRT17. U2OS cells were transfected with the indicated siRNAs for three days, followed by
quantitative RT-PCR using KRT17 primers. (C) U2OS cells were transfected with the indicated siRNAs for three days, followed by quantitative RT-PCR
using the E-cadherin primer set. Cycling-time values were normalized to the housekeeping gene cyclophilin B. Each PCR reaction was performed in
triplicate, and error bars indicate the standard deviation of three separate experiments.
doi:10.1371/journal.pone.0003255.g002
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(Figure 6B). Consistent with previous reports [46], PIASxb bound
to both GST-SUMO1 and GST-SUMO2. By contrast, ZNF198
bound preferentially to GST-SUMO2. We could not detect
binding of LSD1, CoREST, or HDAC1 to either GST-SUMO1
or GST-SUMO2. Therefore, our results confirm that ZNF198
binds to SUMO2 non-covalently and suggest that the reported
non-covalent binding between LSD1 and SUMO2 in human cell
lysates is likely indirect and mediated through ZNF198.
We next tested how sumoylation of HDAC1 might influence its
interaction with ZNF198. We performed FLAG IPs with either
sumoylated or free HDAC1-FLAG as bait (Figure 6C). ZNF198
Figure 3. ZNF198 binds preferentially to the intact LSD1–CoREST–HDAC1 (LCH) ternary complex. (A) Recombinant His6-ZNF198 purified
from Sf9 cells was treated with TEV protease and analyzed by SDS-PAGE followed by Coomassie staining. TEV protease digestion removed the His6-
tag and caused the protein to migrate faster, thus confirming the identity of the band as His6-ZNF198. (B) Recombinant His6-ZNF198 (6 mg) was
added to glutathione-agarose beads that had been preincubated with 1 mg GST-CoREST, 2 mg HDAC1-FLAG, or 3 mg His-LSD1 as indicated. When
indicated, TCP or TSA were present for the entire procedure. After washing, bound proteins were detected by western blotting with the indicated
antibodies. (C) GST pull-downs assays were performed as in (B), except that bound proteins were stained with Coomassie blue. The bands belonging
to His6-ZNF198, His6-LSD1, GST-CoREST, and HDAC1-FLAG are labeled. (D) ZNF198 competes with REST for binding to the LCH complex. HDAC1-FLAG
(1 mg) and the His6-LSD1–His6-CoREST binary complex (3 mg) were preincubated with anti-FLAG M2 agarose in the indicated combinations. After
washing,
35S-REST was added to each binding reaction in the presence or absence of His6-ZNF198 (10 mg). Bound REST was detected using a
phosphoimager (upper panel). The intensities of REST bands in each reaction were quantified and normalized to lane 5. The values were averages of
two experiments. Proteins bound to the anti-FLAG beads were also analyzed by SDS-PAGE and stained with Coomassie blue (lower panel). Note that
His6-CoREST and HDAC1-FLAG migrate at the same position on the gel.
doi:10.1371/journal.pone.0003255.g003
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binding to HDAC1 was greatly enhanced by HDAC1 sumoyla-
tion, even though a minor fraction of HDAC1 was sumoylated in
this particular assay. As a control, this minimal sumoylation of
HDAC1 did not perturb its binding to CoREST, because the
majority of HDAC1 remained unsumoylated and retained the
ability to bind to CoREST (Figure 6C). Thus, sumoylation of
HDAC1 weakens its binding to CoREST, but enhances its
binding to ZNF198 in vitro.
Many non-covalent binding partners of SUMO are efficiently
sumoylated in vitro [46,47]. Consistent with a previous report [35],
ZNF198 was efficiently sumoylated in vitro (Figure S2A). Many
efficient SUMO substrates with SUMO binding capacity, such as
RanBP2 and PIASxb, are also SUMO ligases [46,47]. ZNF198,
however, failed to stimulate the sumoylation of either LSD1 or
HDAC1 in vitro (Figure S2B). Therefore, we do not have evidence
to suggest that ZNF198 functions as a SUMO ligase.
MYM-type zinc fingers of ZNF198 mediate its interactions
with the LCH complex and sumoylated HDAC1
We next mapped the regions of ZNF198 required for binding to
the ternary LCH complex or HDAC1-SUMO2. We used
recombinant FLAG-tagged HDAC1-SUMO2, HDAC1, or
LSD1–CoREST–HDAC1 as baits. As expected, full-length
ZNF198 bound to both SUMO2-HDAC1 and LSD1–CoR-
EST–HDAC1, but not to HDAC1 alone (Figure 7A). Analysis of a
series of truncation mutants of ZNF198 revealed that the central
region of ZNF198 containing the 10 tandem MYM-type zinc
fingers was necessary and sufficient for binding to both SUMO2-
HDAC1 and LSD1–CoREST–HDAC1 (Figure 7A). Further
mapping revealed that a small ZNF198 fragment containing two
zinc fingers, MYM8-9, was sufficient for binding to the LCH
complex in vitro (Figure 7A). MYM8-9 could also be co-
immunoprecipitated with LSD1 from HeLa cell lysates
(Figure 7B), although it was unclear whether it bound LSD1 as
efficiently as the wild-type ZNF198. By contrast, efficient binding
of ZNF198 to SUMO2-HDAC1 required larger fragments of
ZNF198 containing most of its MYM-type zinc fingers (Figure 7A).
Notably, ZNF198 has three putative SUMO interaction motifs
(SIMs) [38]. Deletion of the N-terminal region containing SIM1
and SIM2 or mutation of SIM3 did not affect the binding of
ZNF198 to HDAC1-SUMO2 (Figure 7A), indicating that none of
these putative SIM motifs of ZNF198 are important for HDAC1-
SUMO2 binding. Thus, zinc fingers 8 and 9 of ZNF198 mediate
Figure 4. ZNF198 binds to chromatin through its P/V-rich domain. (A) HeLa Tet-on cells were transfected with the indicated Myc-tagged
ZNF198 constructs along with GFP-MCM7. Cells were either fixed directly (–Extraction) or extracted prior to fixation (+Extraction) and stained with
anti-Myc antibody (red) and DAPI (blue). GFP is shown in green. (B) Summary of the staining data described in (A). The ZNF198 fragments are shown
on the left while the percentages of GFP-positive cells that were also Myc-positive after extraction are shown on the right. More than 30 GFP-positive
cells from 10 random fields were counted for each fragment. The boundaries of ZNF198 fragments are indicated by triangles.
doi:10.1371/journal.pone.0003255.g004
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for the binding of ZNF198 to HDAC1-SUMO2.
Discussion
Functions of ZNF198-like proteins in transcriptional
repression
Consistent with a role of ZNF198 in transcriptional regulation,
several well established transcriptional repressors, including LSD1,
CoREST and HDAC1/2, are major binding proteins of ZNF198
in vivo. Interestingly, ZNF198 only interacts with the intact LSD1–
CoREST–HDAC1 (LCH) ternary complex. Moreover, ZNF198-
and REST-binding to LCH are mutually exclusive. Expectedly,
ZNF198-like proteins are dispensable for the LSD1-mediated
repression of REST-responsive neuron-specific genes in non-
neuronal cell lines, such as HeLa and U2OS. This created a
serious challenge for our studies on ZNF198, because most known
LSD1-repressed genes are REST-responsive. Despite this difficul-
ty, we managed to show that ZNF198-like proteins are required
for the transcriptional repression of E-cadherin, a well-established
LSD1-repressed gene that is not REST-responsive. Identification
of additional genes whose repression requires ZNF198-like
proteins is needed to fully understand their biological functions.
We have further shown that ZNF198 binds directly to
chromatin in part through its proline/valine-rich domain.
Depletion of ZNF198 reduces the amount of chromatin-bound
Figure 5. ZNF198-like proteins regulate the chromatin association of LSD1. (A) HeLa Tet-on cells were transfected with the indicated
siRNAs: Luc (firefly luciferase), MYM (ZNF198, ZNF261, and ZNF262), or LSD1. Lysates from these RNAi cells were immunoprecipitated with either anti-
ZNF198 (top panel) or anti-LSD1 (middle panel). The IPs and the lysates (bottom panel) were blotted with the indicated antibodies. (B) After RNAi of
the indicated proteins, nuclear pellets were generated by subjecting HeLa Tet-on cells to hypotonic lysis followed by centrifugation. Normalized
samples from each step were subjected to SDS-PAGE and blotted with the indicated antibodies. (C) Nuclear pellets in lanes 7–9 in (B) were subjected
to extraction with a high-salt buffer. Normalized samples from each step were blotted with the indicated antibodies. (D) HeLa cells transfected with
siLuc were subjected to fractionation as in B. The nuclear pellet in lane 7 in (B) was digested with micrococcal nuclease (MNase) followed by
extraction with 2 mM EDTA. Supernatants (S) and pellets (P) were blotted with the indicated antibodies.
doi:10.1371/journal.pone.0003255.g005
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one possible mechanism by which ZNF198-like proteins facilitate
the functions of the LSD1–CoREST–HDAC1-containing core-
pressor complexes is to recruit or stabilize the LSD1–CoREST–
HDAC1 ternary complex on chromatin. Because we have so far
failed to detect ZNF198 at specific promoters using ChIP, it
remains to be determined whether ZNF198-like proteins are
required for the stable association of the LCH complex at specific
promoters. It will also be interesting to test whether, in addition to
tethering the LCH complex to chromatin, ZNF198 directly
facilitates the demethylation or deacetylation or both of nucleo-
somes by the LCH complex.
ZNF198 and sumoylation of HDAC1
Sumoylation of HDAC1 is required for its function in
transcriptional repression [37,48]. For example, cells stably
expressing wild-type HDAC1, but not its sumoylation-deficient
mutant, show cell cycle defects [37]. The sumoylation-deficient
mutant of HDAC1 also shows lower deacetylase activity [37,48],
suggesting that sumoylation is required for the full activation of the
catalytic activity of HDAC1. We show that HDAC1 sumoylation
inhibits its binding to CoREST. Our finding is consistent with
previous findings that the C-terminus of HDAC1 mediates its
interactions with cofactors [49] and mutation of the HDAC1
sumoylation sites does not disrupt cofactor binding [37].
HDAC1 and LSD1 exhibit positive cooperativity in deacetylat-
ing and demethylating nucleosomes. CoREST bridges the
interaction between HDAC1 and LSD1. Disruption of the
HDAC1–CoREST interaction by HDAC1 sumoylation is thus
expected to abolish the positive cooperativity between HDAC1
and LSD1. Paradoxically, sumoylation of HDAC1 is required for
its function and possibly activity. Our finding that sumoylation of
HDAC1 enhances its binding toward ZNF198 provides one
possible way to resolve the paradox of HDAC1 sumoylation.
Through its abilities to bind multiple components of the LCH
complex and to sumoylated HDAC1, ZNF198 may antagonize the
disruption of the HDAC1–CoREST interaction by HDAC1
sumoylation and preserve the integrity of the LCH complex on
chromatin. The physiological significance of these in vitro findings
remains to be established.
MYM-type zinc fingers as protein-protein interaction
modules
ZNF198 has been proposed to recruit transcriptional corepres-
sors to specific promoters through sequence-specific DNA-binding,
a function that is analogous to REST. This hypothesis largely
stems from the fact that both ZNF198 and REST contain tandem
zinc fingers and bind to the LCH complex [18,20,21]. Further-
more, ZNF198 competes with REST for CoREST-binding.
However, the tandem zinc fingers of REST are Kru ¨ppel-like zinc
fingers that mediate sequence-specific DNA-binding to RE1-
elements in promoters [50,51]. Structure comparison reveals that
the MYM-type zinc fingers in ZNF198 have a fold that is distinct
from that of the Kru ¨ppel-like zinc fingers (Figure 7C). In
particular, the long a-helix that mediates DNA binding in
Kru ¨ppel-like zinc fingers [52] is much shorter in the MYM-type
zinc fingers. Therefore, the MYM-type zinc fingers are unlikely to
bind to DNA in a manner similar to the Kru ¨ppel-like zinc fingers.
In fact, a search using the Dali server (http://www.ebi.ac.uk/dali)
revealed that the fold of MYM-type zinc fingers is most related to
that of the LIM (Lin11, Isl-1 & Mec-3) domain. LIM domains are
also often found in tandem repeats and mediate protein-protein
interactions [53]. The structural similarity between the MYM and
Figure 6. Sumoylation of HDAC1 weakens its interaction with
CoREST, but enhances its binding to ZNF198. (A) HDAC1-FLAG
(40 ng) was incubated with SUMO2 and sumoylation enzymes with or
without ATP. The reaction mixtures were then added to glutathione-
agarose beads that had been preincubated with buffer or GST-CoREST
(1 mg). After washing, bound (top panel) and unbound (bottom panel)
proteins were blotted with anti-FLAG. The sumoylated and un-
sumoylated HDAC1 bands are labeled. (B) The indicated
35S-labeled in
vitro translated proteins were incubated with glutathione-agarose
beads bound with 10 mg of GST, GST-SUMO1, or GST-SUMO2. The
bound proteins were separated by SDS-PAGE, stained with Coomassie
blue (bottom panel, a representative image), and analyzed using a
phosphoimager (top panel). (C) HDAC1-FLAG (1 mg) bound to anti-
FLAG M2 agarose beads was incubated with SUMO2 and sumoylation
enzymes with or without ATP. After washing, either His6-ZNF198 (6 mg)
or GST-CoREST (2 mg) was added to the beads. The bound proteins
were blotted with the indicated antibodies.
doi:10.1371/journal.pone.0003255.g006
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mediating protein-protein interactions.
In conclusion, we have revealed a functional requirement of
ZNF198-like proteins in transcriptional repression of LSD1-
repressed genes that are not REST-responsive. Our results further
suggest the following model to explain the mechanism by which
ZNF198 promotes the functions of LSD1 (Figure 8). In this model,
ZNF198 binds to chromatin and recruits the LSD1–CoREST–
HDAC1 ternary complex to chromatin. The MYM-type zinc
fingers of ZNF198 mediate its interactions with the LCH complex
and with sumoylated HDAC1. Through its ability to engage in
multiple protein-protein interactions, ZNF198 stabilizes the LCH
Figure 7. MYM-type zinc fingers of ZNF198 mediate its binding to the LCH complex and HDAC1-SUMO2. (A)
35S-labeled ZNF198
fragments and mutants were incubated with anti-FLAG beads that had been preincubated with HDAC1-SUMO2, HDAC1, or the LSD1–CoREST–
HDAC1 complex. After washing, the bound proteins were visualized by autoradiography and Coomassie blue staining (bottom panel). Three putative
SUMO-interacting motifs (SIMs) are indicated. The SIM3 mutant contains V483A, L484A, and V485A mutations. (B) HeLa Tet-on cells were transfected
with the indicated constructs for 24 hours. Lysates and the Myc IPs of the transfected cells were blotted with the indicated antibodies. (C) Ribbon
drawings of three Kru ¨ppel-like zinc fingers bound to DNA (PDB ID: 1ZAA; left) and a MYM-type zinc finger from ZNF237 (PDB ID: 2DAS; right). Zinc
ions are shown as spheres while zinc-binding ligands are shown in sticks.
doi:10.1371/journal.pone.0003255.g007
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HDAC1 from the complex that is triggered by HDAC1
sumoylation.
Materials and Methods
Protein expression and purification
SUMO-related constructs and protein purification were de-
scribed previously [33]. The coding regions of CoREST and
LSD1 were amplified from human fetal thymus cDNA library (BD
Biosciences) and ZNF198 was amplified from a purchased cDNA
plasmid (Open Biosystems) by PCR. The PCR products were
digested and ligated into appropriate expression vectors. Similar
methods were used to construct plasmids encoding various
ZNF198 fragments. The pSC-b-REST construct was a gift from
Jenny Hsieh.
The full-length His6-LSD1, His6-LSD1–His6-CoREST, or
His6-ZNF198 were expressed in Sf9 insect cells and purified using
a combination of Ni
2+-Sepharose (Amersham) affinity chromatog-
raphy and ion exchange chromatography (Resource Q, Amer-
sham). HDAC1-FLAG was purified with M2 agarose beads
(Sigma) from Sf9 cell lysates and eluted with the FLAG peptide.
GST-CoREST, GST-SUMO1, and GST-SUMO2 were purified
from bacterial lysates using glutathione-agarose resin (Amersham).
Proteins were stored in buffers containing 50 mM Tris-HCl,
pH 8.1, 50–200 mM KCl, 10% glycerol, and 1 mM DTT.
Cell culture and transfections
HeLa Tet-on (BD Biosciences) and U2OS cells were grown in
DMEM (Invitrogen) supplemented with 10% fetal bovine serum,
2 mM L-glutamine, and 100 mg/ml penicillin and streptomycin at
37uC and 5% CO2. DNA and siRNA transfections were performed
with the effectene reagent (Qiagen) and Lipofectamine RNAiMax
reagent (Invitrogen), respectively, according to manufacturer’s
protocols. The siRNA sequences are: 59- GGCCUAGA-
CAUUAAACUGA-39 (LSD1), 59-GGGCCAGACAGCUUAU-
CAA-39 (ZNF198), 59-GACCCUGUGUAAGAACUUU-39
(ZNF261), 59-CACCACCACUAGUAAAGAU-39 (ZNF262).
Cell fractionation
Lysates of HeLa Tet-on cells (2610-cm plates) transfected with
siRNAs for 48 hrs were fractionated as described [44] with one
significant modification. We included an additional high-salt
extraction step using buffer C (10 mM HEPES, pH 7.9, 10 mM
KCl, 300 mM NaCl, 1.5 mM MgCl2, 25% glycerol, 0.1% Triton
X-100, 1 mM DTT, 10 mg/ml protease inhibitor cocktail, and
0.4 mM PMSF).
Immunofluorescence
HeLa Tet-on cells transfected with various plasmids were either
extracted as previously described [43] and then fixed with 4%
paraformaldehyde or directly fixed. All samples were then permea-
bilized with 0.1% Triton-X100 in PBS, and incubated with 1 mg/ml
of anti-Myc (9E10, Roche). After washing, fluorescent secondary
antibodies (Molecular Probes) were added at 1:500 dilutions. The
cells were again washed three times with PBS, counter-stained with
DAPI, and viewed using a 636objective on a Zeiss Axiovert 200 M
microscope. Images were acquired using the Intelligent Imaging
software, and pseudo-colored in Adobe Photoshop.
Antibodies, immunoprecipitation, and immunoblotting
Rabbit polyclonal antibodies against ZNF198 and LSD1 were
generated using a ZNF198 fragment (residues 923–1377) and an
LSD1 fragment (residues 171–852) as the antigens at Zymed and
Yenzym, respectively. The following antibodies were purchased
from Upstate: a-HDAC1 (05-614), a-CoREST (07-455). Large-
scale immuno-purification of ZNF198-containing protein com-
plexes was performed as described [54]. For IP and western
experiments, HeLa Tet-on cells from a 10-cm dish were washed
and harvested in cold PBS 2 days after transfection and lysed in
1 ml of buffer C supplemented with 0.5 mM okadaic acid.
Antibodies immobilized on Affi-prep protein A beads were
incubated with the lysates for 2 hrs at 4uC. After washing, the
beads were dissolved in SDS sample buffer and analyzed by SDS-
PAGE following by immunoblotting. For immunoblotting, crude
sera were used at 1:1000 dilution while purified antibodies were
used at a final concentration of 1 mg/ml.
Figure 8. Proposed mechanisms by which ZNF198 regulates the LSD1–CoREST–HDAC1 complex. See DISCUSSION for details.
doi:10.1371/journal.pone.0003255.g008
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In vitro transcription and translation and in vitro sumoylation
assays were performed as previously described [33]. For binding
assays, HDAC1-FLAG, GST-CoREST, or GST-SUMO1/2
proteins together with other proteins were incubated with 5–
10 ml M2 agarose (Sigma) or glutathione-sepharose 4B (Amer-
sham) beads in 50 ml binding solution (TBS supplemented with
0.05% Tween-20 and 1 mM DTT) for 1 hr. After washing, the
beads were then incubated in 50 ml blocking solution (TBS
supplemented with 0.05% Tween-20, 5% dry milk, 1 mM DTT)
for 1 hr at room temperature. The appropriate recombinant
proteins or 5 ml
35S-labeled in vitro translated proteins were
incubated with the beads for 1 hr at room temperature. Beads
were then washed four times with the binding solution, boiled in
SDS sample buffer, and subjected to SDS-PAGE followed by
Coomassie Blue staining and autoradiography. For binding
reactions containing ZNF198, 100 mM ZnCl2 was included in
all buffers.
Reverse transcription and quantitative PCR
RNAfrom U2OS cells grown on 6-wellplates and transfected with
siRNAs was extracted using TriZOLreagent (Invitrogen) followed by
RNAeasy RNA purification kit (Qiagen). RNA was then subjected to
DNase digestion and inactivation followed by reverse transcription
using random hexamers as primers. 2.5 mlo ft h i sc D N Aw a st h e n
used for quantitative PCR in 20 ml reactions using a 26SYBR Green
mix (Bio-Rad). The primers used were: SCN3A-Fwd (59-ATGCT-
GGGCTTTGTTATGCT-39), SCN3A-Rev (59-TGGCTTGGC-
TTCAGTTTTCT-3); Cyclophilin B-Fwd: (59-GGAGATGGCA-
CAGGAGGAA-39), Cyclophilin B-Rev (59-GCCCGTAGTGCTT-
CAGTTT-39); E-cadherin-Fwd (59-GGATGACACAGCGTGA-
GAGA-39), E-cadherin-Rev (59-ACAGGATGGCTGAAGGT-
GAC-39), NCAM2-Fwd (59-CACGTTCACTGAAGGCGATA-
39), NCAM2-Rev (59-GCTGCCCTTTGACTTCGATA-39).
KRT17-Fwd (59-ATGCAGGCCTTGGAGATAGA-39), KRT17-
Rev (59-AGGGATGCTTTCATGCTGAG-39). All primers were
validated as described [55].
Chromatin immunoprecipitation (ChIP)
ChIP experiments were performed as described [56]. About
1610
7 HeLa Tet-on cells was used for each IP. Quantitative PCR
was performed with 2.5 ml of eluted DNA, using the following
primers: KRT17 ChIP-Fwd (59-GGATAGGCTCTCGGTC-
TCCT-39), KRT17 ChIP-Rev (59-GTCTTTCACCCCACA-
CTGCT-39), GAPDH ChIP-Fwd (59-TGTGCCCAAGACC-
TCTTTTC-39), GAPDH ChIP-Rev (59-TATTGAGGGCAGG-
GTGAGTC-39).
Supporting Information
Figure S1 Domain architecture of MYM domain-containing
proteins. The following color schemes from this illustration are
used throughout the manuscript: MYM-type zinc fingers (MYM,
red); proline/valine-rich domain (P/V-rich, green); Cre-like
domain (CLD, gold); glutamine-rich domain (Q-rich, gray);
potassium-tetramerization domain (K-tetra, black); and transpos-
ase-like domain (teal). Non-cysteine residues at zinc-coordinating
positions in certain MYM domains are indicated by asterisks.
Scale bar indicates 100 amino acids. The Cre-like domain of
KCTD1 was used for 3D-Jury analysis (http://Bioinfo.Pl/Meta).
Found at: doi:10.1371/journal.pone.0003255.s001 (0.50 MB TIF)
Figure S2 ZNF198 does not stimulate the sumoylation of
HDAC1 or LSD1. (A) 35S-labeled in vitro translated ZNF198
was incubated with sumoylation enzymes (E1 and E2) and ATP in
the presence or absence of SUMO2. The reaction mixtures were
separated by SDS-PAGE and analyzed using a phosphoimager.
The bands of unmodified and sumoylated ZNF198 are labeled. (B)
Mixtures of His-LSD1 (300 ng), HDAC1-FLAG (300 ng), and
GST-CoREST (100 ng) were subjected to in vitro sumoylation
reactions in the presence or absence of His-ZNF198 (1–2 mg). The
reaction mixtures were blotted with anti-FLAG (top panel) or anti-
LSD1 (bottom panel).
Found at: doi:10.1371/journal.pone.0003255.s002 (0.33 MB TIF)
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